Intratumoral heterogeneity in gastric cancer: a new challenge to face

M Alsina¹, I Gullo^{2

3

4

5}, F Carneiro^{2

3

4

5}

Affiliations

¹ Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Department of Pathology, Centro Hospitalar de São João, Porto, Portugal.
³ Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.
⁴ Institute of Molecular Pathology and Immunology at the University of Porto (Ipatimup), Porto, Portugal.
⁵ Institute for Research Innovation in Health (i3S), University of Porto, Porto, Portugal.

Free article

Editorial

M Alsina et al. Ann Oncol. 2017.

Free article

. 2017 May 1;28(5):912-913.

doi: 10.1093/annonc/mdx134.

M Alsina¹, I Gullo^{2

3

4

5}, F Carneiro^{2

3

4

5}

¹ Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Department of Pathology, Centro Hospitalar de São João, Porto, Portugal.
³ Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.
⁴ Institute of Molecular Pathology and Immunology at the University of Porto (Ipatimup), Porto, Portugal.
⁵ Institute for Research Innovation in Health (i3S), University of Porto, Porto, Portugal.

No abstract available

Comment on

Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C, Krüger S, Behrens HM, Bock S, Haag J, Kalthoff H, Röcken C. Böger C, et al. Ann Oncol. 2017 May 1;28(5):1005-1014. doi: 10.1093/annonc/mdx047. Ann Oncol. 2017. PMID: 28453696 Free PMC article.